Published in Eur J Clin Microbiol Infect Dis on December 01, 2004
Blood cultures in ambulatory outpatients. BMC Infect Dis (2005) 0.98
Cardiac device infection due to Streptococcus pneumoniae. Can J Infect Dis Med Microbiol (2012) 0.78
Outpatient blood cultures: progress and unanswered questions. Eur J Clin Microbiol Infect Dis (2004) 0.77
Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis (1996) 3.03
Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics (2000) 2.17
Adult patients with occult bacteremia discharged from the emergency department: epidemiological and clinical characteristics. Clin Infect Dis (2001) 1.50
[Detection of bacteremia in patients discharged from an emergency unit: study of 61 cases]. Med Clin (Barc) (1998) 1.38
Blood cultures in adult patients released from an urban emergency department: a 15-month experience. Acad Emerg Med (1996) 1.38
Difficulty in predicting bacteremia in elderly emergency patients. Ann Emerg Med (1992) 1.13
Fever in geriatric emergency patients: clinical features associated with serious illness. Ann Emerg Med (1995) 1.03
A simple index to identify occult bacterial infection in adults with acute unexplained fever. Arch Intern Med (1987) 0.90
Occult bacterial infection in adults with unexplained fever. Validation of a diagnostic index. Arch Intern Med (1990) 0.83
Routine blood cultures from febrile outpatients. Use in detecting bacteremia. JAMA (1976) 0.82
Unexplained fever in the ED: analysis of 139 patients. Am J Emerg Med (2003) 0.80
The yield of blood cultures in a department of emergency medicine. Eur J Emerg Med (2001) 0.79
Infectious disease issues in the emergency department. Clin Infect Dis (1996) 0.75
The value of outpatient blood cultures in the emergency department. Am J Emerg Med (1987) 0.75
[Bacteremia in patients discharged from the emergency unit]. Med Clin (Barc) (2001) 0.75
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst (2000) 6.38
Expression of Snail protein in tumor-stroma interface. Oncogene (2006) 2.68
Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol Appl Pharmacol (1997) 2.42
Locomotion in larval zebrafish: Influence of time of day, lighting and ethanol. Neurotoxicology (2008) 2.12
Common mechanism of toxicity: a case study of organophosphorus pesticides. Toxicol Sci (1998) 2.08
In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis. Int J Antimicrob Agents (2002) 2.07
Effect of various compounds on virgin olive oil stability measured by Rancimat. J Agric Food Chem (1999) 1.58
Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur Respir J (2010) 1.58
Calcified pedicled thrombus in the left ventricle: the fine art of nature. J Thorac Cardiovasc Surg (1997) 1.58
Psoriatic arthritis: clinical response and side effects to methotrexate therapy. J Rheumatol (1992) 1.57
Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res (1999) 1.55
Prenatal diagnosis of sacrococcygeal teratomas by two- and three-dimensional ultrasound. Ultrasound Obstet Gynecol (2002) 1.51
The aesthetic alliance: nurses and medical facials. Dermatol Nurs (1990) 1.39
[Bacteremia caused by Streptococcus agalactiae in adults. Presentation of 6 cases]. Enferm Infecc Microbiol Clin (1991) 1.39
[Ileal endometriosis as a cause of intestinal obstruction]. Rev Esp Enferm Dig (1998) 1.39
Detraining: loss of training-induced physiological and performance adaptations. Part I: short term insufficient training stimulus. Sports Med (2000) 1.39
Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res (2001) 1.34
Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Chemotherapy (2007) 1.34
Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer (2012) 1.32
Treatment of paracoccidioidomycosis with ketoconazole: a three-year experience. Am J Med (1983) 1.30
Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut (2002) 1.26
Cancer antigen 125 associated with multiple benign and malignant pathologies. Ann Surg Oncol (2003) 1.25
Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res Treat (1999) 1.22
Localization of the lipid receptors CD36 and CLA-1/SR-BI in the human gastrointestinal tract: towards the identification of receptors mediating the intestinal absorption of dietary lipids. J Histochem Cytochem (2001) 1.20
Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol Teratol (2009) 1.18
DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3. Oncogene (2008) 1.18
In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis. Int J Antimicrob Agents (2001) 1.17
Paracoccidioidomycosis, (South American blastomycosis). A study of 39 cases observed in Medellin, Colombia. Am J Trop Med Hyg (1970) 1.17
A bibliometric analysis of tuberculosis research indexed in PubMed, 1997-2006. Int J Tuberc Lung Dis (2008) 1.17
Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis. J Antimicrob Chemother (2004) 1.16
Snail1 controls TGF-β responsiveness and differentiation of mesenchymal stem cells. Oncogene (2012) 1.15
Pathogenesis of paracoccidioidomycosis: a model based on the study of 46 patients. Mycopathologia (1976) 1.09
Cardiorespiratory and metabolic characteristics of detraining in humans. Med Sci Sports Exerc (2001) 1.09
Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine. Cancer Gene Ther (2006) 1.08
Detraining: loss of training-induced physiological and performance adaptations. Part II: Long term insufficient training stimulus. Sports Med (2000) 1.06
Muscular characteristics of detraining in humans. Med Sci Sports Exerc (2001) 1.06
Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. Toxicol Sci (1998) 1.05
The gamut of paracoccidioidomycosis. Am J Med (1976) 1.05
Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol Appl Pharmacol (1998) 1.05
SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue. Oncogene (2009) 1.05
Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations. Environ Health Perspect (2001) 1.05
Publication of European Union research on infectious diseases (1991-2001): a bibliometric evaluation. Eur J Clin Microbiol Infect Dis (2004) 1.04
Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance. Ann Oncol (2000) 1.04
Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome. Hum Reprod (1999) 1.04
Creatine supplementation and sprint performance in soccer players. Med Sci Sports Exerc (2000) 1.03
Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Br J Cancer (1999) 1.03
Assessment of endometrial volume by three-dimensional ultrasound prior to embryo transfer: clues to endometrial receptivity. Hum Reprod (1999) 1.02
Clinical evaluation of rapid point-of-care testing for detection of novel influenza A (H1N1) virus in a population-based study in Spain. Clin Microbiol Infect (2010) 1.02
Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer. J Mol Med (Berl) (2011) 1.02
Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. Br J Cancer (1999) 1.01
Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests. Neurology (2004) 1.00
Tissue-specific effects of chlorpyrifos on carboxylesterase and cholinesterase activity in adult rats: an in vitro and in vivo comparison. Fundam Appl Toxicol (1997) 1.00
Gestational exposure to chlorpyrifos: apparent protection of the fetus? Toxicol Appl Pharmacol (1998) 1.00
SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity. Oncogene (2010) 0.99
A modified spectrophotometric method appropriate for measuring cholinesterase activity in tissue from carbaryl-treated animals. Fundam Appl Toxicol (1993) 0.98
Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer. Oncogene (2001) 0.98
Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors. Cancer Res (1996) 0.97
Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain. Clin Microbiol Infect (2005) 0.96
Physiological and performance characteristics of male professional road cyclists. Sports Med (2001) 0.96
Pulmonary mycetoma caused by an atypical isolate of Paecilomyces species in an immunocompetent individual: case report and literature review of Paecilomyces lung infections. Eur J Clin Microbiol Infect Dis (2005) 0.96
Rapid-infusion rituximab in lymphoma treatment. Ann Oncol (2005) 0.96
Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome. Eur J Clin Microbiol Infect Dis (2005) 0.96
An invertebrate model of the developmental neurotoxicity of insecticides: effects of chlorpyrifos and dieldrin in sea urchin embryos and larvae. Environ Health Perspect (2001) 0.95
Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats. Int J Obes Relat Metab Disord (2001) 0.95
Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish. Pharmacol Biochem Behav (2012) 0.95
Characterisation of Salmonella spp. mutants produced by exposure to various fluoroquinolones. Int J Antimicrob Agents (2003) 0.94
TP53 gene mutations in plasma DNA of cancer patients. Genes Chromosomes Cancer (1999) 0.94
Successful use of tissue plasminogen activator in catheter-related intracardiac thrombus of a premature infant. Am J Perinatol (2003) 0.93
Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure. Clin Exp Obstet Gynecol (2012) 0.93
Adenosine deaminase isoenzymes and neopterin in liver cirrhosis. J Clin Gastroenterol (2000) 0.93
Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos. J Biochem Toxicol (1996) 0.93
Rat brain acetylcholinesterase activity: developmental profile and maturational sensitivity to carbamate and organophosphorus inhibitors. Toxicology (1998) 0.93
Behavioral and neurochemical effects of acute chlorpyrifos in rats: tolerance to prolonged inhibition of cholinesterase. J Pharmacol Exp Ther (1993) 0.91
Loss of heterozygosity in the region including the BRCA1 gene on 17q in colon cancer. Cancer Genet Cytogenet (1998) 0.90
Real-time PCR with internal amplification control for detecting tuberculosis: method design and validation. APMIS (2009) 0.90
Comparison of the in vitro sensitivity of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent? Toxicol Appl Pharmacol (1998) 0.90
Influence of body mass and height on the energy cost of running in highly trained middle- and long-distance runners. Int J Sports Med (2002) 0.89
Swimming performance changes during the final 3 weeks of training leading to the Sydney 2000 Olympic Games. Int J Sports Med (2002) 0.89
Factorial study of the BDI in pregnant women. Psychol Med (1994) 0.89
Hormonal responses to training and its tapering off in competitive swimmers: relationships with performance. Eur J Appl Physiol Occup Physiol (1996) 0.89
Molecular epidemiology of tuberculosis in Elche, Spain: a 7-year study. J Med Microbiol (2002) 0.89
Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia. Clin Infect Dis (1994) 0.88
Genetic evidence for coenzyme Q requirement in plasma membrane electron transport. J Bioenerg Biomembr (1998) 0.88
Creatine supplementation as an ergogenic aid for sports performance in highly trained athletes: a critical review. Int J Sports Med (1997) 0.88
Evaluation of phagocytic capacity with a modified flow cytometry technique. Immunol Lett (1995) 0.87
Wild type p73 overexpression and high-grade malignancy in breast cancer. Breast Cancer Res Treat (2001) 0.87
Post-therapy status of paracoccidioidomycosis treated with ketoconazole. Am J Med (1983) 0.87
Haloperidol disrupts lipid rafts and impairs insulin signaling in SH-SY5Y cells. Neuroscience (2010) 0.87
Physiological variables to use in the gender comparison in highly trained runners. J Sports Med Phys Fitness (2004) 0.87
Gestational exposure to chlorpyrifos: comparative distribution of trichloropyridinol in the fetus and dam. Toxicol Appl Pharmacol (1999) 0.87
Comparison of two different PCR detection methods. Application to the diagnosis of pulmonary tuberculosis. APMIS (1997) 0.87